摘 要
标 签
Abstract
中图分类号 O657.7 DOI 10.11973/lhjy-hx201907015
所属栏目 知识与经验
基金项目
收稿日期 2018/12/14
修改稿日期
网络出版日期
作者单位点击查看
引用该论文: 赵梅仙,徐金雷,王峥,梁景乐,张传良,马佳颖,张刚,韩冰,姜桂英. [J]. Physical Testing and Chemical Analysis part B:Chemical Analysis, 2019, 55(7): 824~826
赵梅仙,徐金雷,王峥,梁景乐,张传良,马佳颖,张刚,韩冰,姜桂英. 高效液相色谱法测定加米霉素注射液中抗氧化剂硫代甘油[J]. 理化检验-化学分册, 2019, 55(7): 824~826
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
参考文献
【1】罗显阳.加米霉素及其在牛呼吸系统疾病中的应用[J].广东畜牧兽医科技, 2015,40(1):12-15.
【2】冯克清.加米霉素注射液在治疗肉牛和非泌乳奶牛呼吸系统疾病中的应用研究进展[J].中国兽药杂志, 2016,50(8):66-69.
【3】EVANS N J, BROWN J M, HARTLEY C, et al. Antimicrobial susceptibility testing of bovine digital dermatitis treponemes identifies macrolides for in vivo efficacy testing[J]. Veterinary Microbiology, 2012,160(3/4):496-500.
【4】TORRES S, THOMSON D U, BELLO N M, et al. Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease[J]. American Journal of Veterinary Research, 2013,74(6):839-846.
【5】HIDEBRAND F, VENNER M, GIGUERE S. Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia[J].Journal of Veterinary Internal Medicine, 2015,29(1):333-338.
【6】LECHTENBERG K, TESSMAN R K, CHESTER S T. Efficacy of gamithromycin injectable solution for the treatment of mycoplasma bovis induced pneumonia in cattle[J]. International Journal of Applied Research in Veterinary Medicine, 2011,9(3):233-240.
【7】LECHTENBERG K, DANIELS C S, ROYER G C, et al. Field efficacy study of gamithromycin for the control of bovine respiratory disease in cattle at high risk of developing the disease[J]. International Journal of Applied Research in Veterinary Medicine, 2011,9(2):184-192.
【8】MORGAN S, MACKAY A. Summary of product characteristics[M]. Springer Berlin Heidelberg:Encydopedia of Psychopharmacology, 2010.
【9】FDA. Freedom of information summary original new animal drug application[EB/OL].[2012-08].https://www.fda.gov/downloads/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm277806.pdf.
【10】虞锐鹏,陈尚卫,朱松,等.反相高效液相色谱法测定抗氧化剂硫代二丙酸双十二醇酯[J].理化检验-化学分册, 2011,47(5):572-576.
【11】罗成玉,张耀明,王锋,等.高效液相色谱法测定食用油中5种抗氧化剂的含量[J].理化检验-化学分册, 2011,47(6):687-689.
【2】冯克清.加米霉素注射液在治疗肉牛和非泌乳奶牛呼吸系统疾病中的应用研究进展[J].中国兽药杂志, 2016,50(8):66-69.
【3】EVANS N J, BROWN J M, HARTLEY C, et al. Antimicrobial susceptibility testing of bovine digital dermatitis treponemes identifies macrolides for in vivo efficacy testing[J]. Veterinary Microbiology, 2012,160(3/4):496-500.
【4】TORRES S, THOMSON D U, BELLO N M, et al. Field study of the comparative efficacy of gamithromycin and tulathromycin for the control of undifferentiated bovine respiratory disease complex in beef feedlot calves at high risk of developing respiratory tract disease[J]. American Journal of Veterinary Research, 2013,74(6):839-846.
【5】HIDEBRAND F, VENNER M, GIGUERE S. Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia[J].Journal of Veterinary Internal Medicine, 2015,29(1):333-338.
【6】LECHTENBERG K, TESSMAN R K, CHESTER S T. Efficacy of gamithromycin injectable solution for the treatment of mycoplasma bovis induced pneumonia in cattle[J]. International Journal of Applied Research in Veterinary Medicine, 2011,9(3):233-240.
【7】LECHTENBERG K, DANIELS C S, ROYER G C, et al. Field efficacy study of gamithromycin for the control of bovine respiratory disease in cattle at high risk of developing the disease[J]. International Journal of Applied Research in Veterinary Medicine, 2011,9(2):184-192.
【8】MORGAN S, MACKAY A. Summary of product characteristics[M]. Springer Berlin Heidelberg:Encydopedia of Psychopharmacology, 2010.
【9】FDA. Freedom of information summary original new animal drug application[EB/OL].[2012-08].https://www.fda.gov/downloads/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm277806.pdf.
【10】虞锐鹏,陈尚卫,朱松,等.反相高效液相色谱法测定抗氧化剂硫代二丙酸双十二醇酯[J].理化检验-化学分册, 2011,47(5):572-576.
【11】罗成玉,张耀明,王锋,等.高效液相色谱法测定食用油中5种抗氧化剂的含量[J].理化检验-化学分册, 2011,47(6):687-689.
相关信息